Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
about
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresMeasurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS/MS quantification.Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infectionReduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women.Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.Development and validation of an LC-MS/MS quantitative method for endogenous deoxynucleoside triphosphates in cellular lysate.Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.Validation and Application of a Liquid Chromatography-Tandem Mass Spectrometry Method To Determine the Concentrations of Sofosbuvir Anabolites in Cells.Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing studyTenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients.Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-EmtricitabineDetermination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS/MSQuantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.Mass spectrometry analysis of nucleosides and nucleotides.Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry.Feasibility, Acceptability And Adherence With Short Term Hiv Pre-Exposure Prophylaxis In Female Sexual Partners Of Migrant Miners In Mozambique.Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: a focus on antiviral drugs.Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State.Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels.Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms.Intrahepatic antiviral quantification in a patient undergoing orthotopic cadaveric liver transplantationCritical need for appropriate mucosal sample collection to determine relational animal pharmacokinetic-pharmacodynamic models in HIV prevention.Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells.Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites.Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS.
P2860
Q27313352-260C6AD3-A0D7-4716-8393-2A5AD2D1F4BCQ34034418-8A6E3973-79A2-42EF-A84B-586171D8661CQ34675000-C4AAD05D-316F-4225-970D-8B99E19DBA50Q34979638-58CA7736-ABA7-4D41-81C5-BFE4C2E32D2AQ35169059-19D9CDB0-F725-4A57-A8E5-2C73724B4EFBQ35174468-041B1DB5-B416-4844-B1C8-26657AC9A7CCQ35230243-AEF23AD3-6237-454B-B6F6-C29B75E56A88Q35473669-49A902E0-EC7A-488A-B4DA-8348A78DF109Q36018600-0B0854CC-BA60-4057-9316-F426CE80B1ADQ36111812-E8E616CB-8A88-4F5B-8A48-D9F4CBE27BA4Q36188725-569A9C9E-0AFA-46E5-A6AE-03C6B5F8852AQ36290604-3C27A77F-1161-441B-8CFF-2CF54B6DDFC0Q36306935-C41DBC2B-50D1-4DE7-AB27-5666071EAB96Q36406923-2548B6FC-CAD2-433F-B6EB-75B9707DBCF7Q36432228-2D9984DF-E427-4916-AD08-189ACF727B01Q36554980-6355B224-9664-418C-8776-7225C627649FQ36609638-9ECCC3B2-2EDD-4C3F-83EE-99F39180E14AQ36901498-3CF09594-6655-41FB-A16F-6C07323B9656Q37042094-3F3E7408-5361-42E3-B2BF-CDCA75D8EA61Q37203781-0F4DAC22-5339-4483-91AA-FD51B5612BD2Q37329536-3FFD213A-2593-42B2-A5C7-27636EA2DF86Q37347434-8E308A3D-0AAE-444A-A335-74FD597A7E0EQ37358658-B918E023-FA7B-40A1-A773-097B3F38E5D1Q38166984-8B7B46F1-F967-467C-8BE3-5B02ECEDA930Q38256679-CF53473D-93DE-4E5F-A51A-2A4B9919244DQ38641084-B46AF65F-F0D6-44A5-873D-DCDEACF9D0CCQ38850925-1076F102-71A8-4C9B-9BEF-9C8F5A00EF98Q39434360-D9B5DEE3-6796-4BDF-810B-CFD6E7834119Q39488594-C4759CB3-739B-4C1F-8C20-823225D76087Q40281007-AD506E1E-377C-4CE3-8D6B-92F7742B07A0Q40385212-142D4FF4-BD5B-4336-92CD-1997860CE685Q41471865-85FBE6F6-81FE-4A12-AB2B-5EAC25D90CE0Q42680456-CB29A137-9422-455D-897F-C9A97F133CABQ42932227-094F516F-EDDD-431A-A18F-E1E0A5CA7759Q46333832-881AB269-C4DB-4054-B919-8C65AC64B0B0Q47556636-E376236C-65E6-46D2-9F8A-4B343A6C501CQ49810962-F81D2451-1949-433B-B91B-F6C2BE31F95EQ50551234-2BB6421A-E6E3-4F52-BC83-D60B50FC522DQ52374199-AB488535-961F-42F2-A26E-262E7D81ABA4Q52666512-01AC33AB-D5C1-4BC7-97A9-DE1F030BD854
P2860
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Determination of nucleoside an ...... -sensitive LC-MS/MS detection.
@en
type
label
Determination of nucleoside an ...... -sensitive LC-MS/MS detection.
@en
prefLabel
Determination of nucleoside an ...... -sensitive LC-MS/MS detection.
@en
P2093
P2860
P1476
Determination of nucleoside an ...... -sensitive LC-MS/MS detection.
@en
P2093
Brandon Klein
Jennifer J Kiser
Jia-Hua Zheng
Joseph E Rower
Lane R Bushman
Michelle L Ray
Peter L Anderson
P2860
P304
P356
10.1016/J.JPBA.2011.05.039
P577
2011-06-06T00:00:00Z